Recorded Chinese product: 司坦唑醇片司坦唑醇片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 广东彼迪药业有限公司Chinese legal name: 广东彼迪药业有限公司
主要成分Active Ingredients
- 司坦唑醇Sitan Zuochun
药物知识说明
司坦唑醇是一种在国家药监局注册认定的药品。该药品含有司坦唑醇-b8ae65c4等成分。
该药品关联的活性成分包括：司坦唑醇Sitan Zuochun。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：广东彼迪药业有限公司Chinese legal name: 广东彼迪药业有限公司。
您可以探索含有相同成分的其他药品：司坦唑醇-b8ae65c4成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 司坦唑醇片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 司坦唑醇Sitan Zuochun.
Manufacturers recorded for this product: 广东彼迪药业有限公司Chinese legal name: 广东彼迪药业有限公司.
Explore other medicines containing the same ingredient: 司坦唑醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 司坦唑醇片Recorded Chinese product: 司坦唑醇片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 2mg2 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 广东彼迪药业有限公司Chinese legal name: 广东彼迪药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H44023392
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H44023392
Manufacturer
Chinese legal name: 广东彼迪药业有限公司
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H44023392
生产企业
广东彼迪药业有限公司
适应症
本品用于。1. 遗传性血管神经性水肿的预防和治疗。 2. 严重创伤、慢性感染、营养不良等消耗性疾病。
用法用量
1.成人和青少年常用量：
(1)预防和治疗遗传性血管神经性水肿：口服，开始一次2mg，一日3次，女性可一次2mg。应根据病人的反应个体化给药。如治疗效果明显，可每间隔1～3月减量，直至每日2mg维持量。但减量过程中，须密切观察病情。
(2)用于慢性消耗性疾病、手术后体弱、创伤经久不愈等治疗：口服，一日3次，一次2～4mg，女性酌减。
2.小儿常用量：用于遗传性血管神经性水肿：
(1)6岁以下，每日口服1mg，仅在发作时应用。
(2)6～12岁，每日口服2mg，仅在发作时应用。
不良反应
1. 女性：长期使用可能会有痤疮，多毛，阴蒂肥大，闭经或月经紊乱等症。 2. 男性：长期使用可能会有痤疮，精子减少，精液减少。 3. 肝脏：GOP，GTP上升，黄疸。 4. 消化系统：恶心，呕吐，消化不良，腹泻。 5. 电解质：水钠潴留，水肿。 6. 皮肤：皮疹，颜面潮红。
禁忌
严重肝病、肾脏病、心脏病、高血压患者、孕妇及前列腺癌患者禁用。
注意事项
卟啉症患者、前列腺肥大、糖尿病患者慎用。
贮藏
遮光、密封保存
规格
2mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.